Professor Suk Woo Nam received his M.S. and Ph.D. in Pharmacy from Sungkyunkwan University. He subsequently completed his postdoctoral training at the Laboratory of Pathology, National Cancer Institute (NIH), where he established a strong foundation in cancer research. He later served as a Senior Scientist at the Genome Institute of Singapore, conducting research on genomics-based disease mechanisms. He is currently a Professor in the Department of Pathology at the College of Medicine, The Catholic University of Korea, and Director of the Functional RNomics Research Center.
Professor Nam has published over 254 SCI-indexed papers and holds 28 patents, demonstrating globally recognized expertise in RNA biology, transcriptomics, and therapeutic target discovery. In recognition of his outstanding scientific contributions, he received the Basic Medical Science Award (Pfizer Medical Research Award) from the National Academy of Medicine of Korea in 2014, the Minister of Health and Welfare Award in 2015, and the Minister of Environment Award in 2013. He has also served as a reviewer for the Ho-Am Prize in Medicine and as an evaluator for KOSDAQ technology special listings in the field of RNA therapeutics, contributing significantly to both academia and industry.
His research focuses on functional transcriptomics and RNA-based disease mechanisms, with particular emphasis on identifying novel therapeutic targets for intractable diseases, including cancer, metabolic disorders, and fibrotic diseases. His laboratory is actively engaged in translational research aimed at developing RNA-based therapeutics. By modulating miRNA and RNA regulatory networks, his work seeks to reprogram immune responses and establish innovative therapeutic strategies that bridge basic research and clinical applications.

Professor Seong-beom Lee graduated from the College of Medicine at the Catholic University of Korea in 1991 and obtained his board certification as a specialist in Surgical Pathology in 1996. He worked as a researcher at the Department of Life Sciences at POSTECH from 1996 to 1999 and received his Ph.D. from the Graduate School of the Catholic University of Korea in 2000. Afterward, he served as a researcher at the Department of Biology at the University of Notre Dame in the United States from 2003 to 2005. He has been working at the Department of Pathology at the Catholic University of Korea College of Medicine since 1996. Professor Lee's main research interests focus on the cell invasion mechanism and  the mechanism of phagosome maturation inhibition of Mycobacterium leprae, the causative agent of Hansen's disease. Additionally, Professor Lee provides mobile medical services for patients with Hansen's disease. He was awarded the "Teacher of the Year" award in Korea in 2013.

Professor Mi-La Cho of the Department of Pathology is a leading figure in translational research, bridging the gap between basic science and clinical practice. Her research focuses on elucidating the pathogenesis of intractable immune diseases and developing innovative therapeutic solutions.
To overcome the limitations of conventional animal models, Professor Cho has established the world’s first preclinical models transplanted with patient-derived immune cells and tissues, which faithfully reflect the clinical characteristics of human patients. Utilizing these models, she conducts translational studies to precisely analyze complex pathogenic mechanisms and develop treatments with high clinical applicability.
Currently, her research is centered on a next-generation approach mitochondrial transplantation technology to develop pathogen-selective immunomodulatory therapies for autoimmune and transplant-related diseases.

Professor Younggwang Kim earned his M.D. from Yonsei University College of Medicine and became a board-certified neurologist. He received his M.S. degree for research on Parkinson’s disease and Parkinson’s disease dementia, and later obtained his Ph.D. for his studies on genome editing and high-throughput genetic screening.

From 2021 to 2023, he served as a research assistant professor in the Department of Pharmacology at Yonsei University College of Medicine, and in 2023, he joined the Department of Pathology at the Catholic University College of Medicine.

Professor Kim has conducted large-scale functional screening of tumor-associated genetic alterations using CRISPR-based genetic libraries, and published these findings twice in leading scientific journals, including Nature Biotechnology. In recognition of his research achievements, he received the 2025 Boehringer Ingelheim–Korean Academy of Medical Sciences (KAMS) Wunsch Medical Award Young Medical Scientist Award.

His laboratory focuses on developing novel gene therapies for intractable genetic diseases using gene-editing technologies such as CRISPR-Cas9. The team also investigates the genetic variants underlying human diseases, discovers new gene correction platforms, and identifies key regulators that can enhance the efficacy of cell-based therapies through library-based high-throughput screening. These studies are conducted in close collaboration with multiple clinical departments, including Neurology, Rheumatology, and Neurosurgery, to translate basic research findings into clinically applicable therapeutic strategies.